D073-0035 Screening compound: N-(2-cyclohexyl-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazol-8-yl)-N-(4-methyl-1-phthalazinyl)amine

D073-0035 Screening compound: N-(2-cyclohexyl-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazol-8-yl)-N-(4-methyl-1-phthalazinyl)amine
D073-0035 Screening compound: N-(2-cyclohexyl-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazol-8-yl)-N-(4-methyl-1-phthalazinyl)amine alternative view

Chemical Structure Depiction of ChemDiv screening compound D073-0035
N-(2-cyclohexyl-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazol-8-yl)-N-(4-methyl-1-phthalazinyl)amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D073-0035

Molecular Formula

C25H28N6 (C25 H28 N6)

Compound Name

N-(2-cyclohexyl-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazol-8-yl)-N-(4-methyl-1-phthalazinyl)amine

IUPAC name

11-cyclohexyl-N-(4-methylphthalazin-1-yl)-1811-triazatricyclo[7.4.0.0^{27}]trideca-2(7)358-tetraen-5-amine

SMILES

Cc(c1ccccc11)nnc1Nc(cc1)cc2c1n(CCN(C1)C3CCCCC3)c1n2

InChI

InChI=1S/C25H28N6/c1-17-20-9-5-6-10-21(20)25(29-28-17)26-18-11-12-23-22(15-18)27-24-16-30(13-14-31(23)24)19-7-3-2-4-8-19/h5-6,9-12,15,19H,2-4,7-8,13-14,16H2,1H3,(H,26,29)

InChI Key

UFVUNMIHMUYDSG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06003322

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.579

Distribution Coefficient, logD

2.947

Water Solubility, LogSw

-4.33

Polar Surface Area

46.067

Acid Dissociation Constant (pKa)

18.56

Base Dissociation Constant (pKb)

9.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

D073-0035 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D073-0035 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D073-0035?
Check Price and Availability of D073-0035, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D073-0035 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D073-0035
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D073-0035
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D073-0035 available by request